Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone ameliorates postoperative pain by regulating macrophage polarization

被引：0
|
作者：
Godai, Kohei [1 ]
Hasegawa-Moriyama, Maiko [1 ]
Ohnou, Tetsuya [1 ]
Kanmura, Yuichi [1 ]
机构：
[1] Kagoshima Univ, Sch Med, Dept Anethesiol, Kagoshima 8908520, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2013年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：188P / 188P
页数：1
相关论文
共 50 条
  • [21] Peroxisome proliferator-activated receptor-gamma in normal human pregnancy and miscarriage
    Toth, Bettina
    Bastug, Mehmet
    Mylonas, Ioannis
    Scholz, Christoph
    Makovitzky, Josef
    Kunze, Susanne
    Thaler, Christian
    Friese, Klaus
    Jeschke, Udo
    ACTA HISTOCHEMICA, 2009, 111 (04) : 373 - 379
  • [22] Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma
    Hsu, Hui-Tzu
    Chi, Chin-Wen
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2014, 1 : 127 - 134
  • [23] Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARγ)-specific agonist, as a modulator in experimental acute pancreatitis
    Celinski, Krzysztof
    Madro, Agnieszka
    Prozorow-Krol, Beata
    Korolczuk, Agnieszka
    Cichoz-Lach, Halina
    Slomka, Maria
    Korobowicz, Elzbieta
    MEDICAL SCIENCE MONITOR, 2009, 15 (01): : BR21 - BR29
  • [24] Effect of peroxisome proliferator-activated receptor γ agonist, rosiglitazone, on dedifferentiated thyroid cancers
    Philips, JC
    Petite, C
    Willi, JP
    Buchegger, F
    Meier, CA
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (12) : 1183 - 1186
  • [25] Peroxisome proliferator-activated receptor-gamma agonist, troglitazone has anticancer effect on breast cancer cells
    Youn, H. J.
    Jung, S. H.
    Park, M. H.
    Yoon, J. H.
    EJC SUPPLEMENTS, 2008, 6 (07): : 84 - 84
  • [26] Amelioration of progressive renal injury by peroxisome proliferator-activated receptor-gamma (PPARγ) agonist in aging rats
    Yang, H-C
    Ma, L-J
    Fogo, A. B.
    LABORATORY INVESTIGATION, 2008, 88 : 297A - 297A
  • [27] Amelioration of progressive renal injury by peroxisome proliferator-activated receptor-gamma (PPARγ) agonist in aging rats
    Yong, H-C
    Ma, L-J
    Fogo, A. B.
    MODERN PATHOLOGY, 2008, 21 : 297A - 297A
  • [28] The peroxisome proliferator-activated receptor gamma (PPARγ) agonist, rosiglitazone, ameliorates neurofunctional and neuroinflammatory abnormalities in a rat model of Gulf War Illness
    Keledjian, Kaspar
    Tsymbalyuk, Orest
    Semick, Stephen
    Moyer, Mitchell
    Negoita, Serban
    Kim, Kevin
    Ivanova, Svetlana
    Gerzanich, Volodymyr
    Simard, J. Marc
    PLOS ONE, 2020, 15 (11):
  • [29] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA AGONIST IMPROVES SURVIVAL IN A MURINE MODEL OF POST-BURN INFECTION BY MODULATING THE MACROPHAGE FUNCTION
    Miyazaki, H.
    Kinoshita, M.
    Seki, S.
    Saitoh, D.
    SHOCK, 2015, 43 (06): : 38 - 38
  • [30] Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcoma
    Akihiko Takeuchi
    Norio Yamamoto
    Toshiharu Shirai
    Katsuhiro Hayashi
    Shinji Miwa
    Seiichi Munesue
    Yasuhiko Yamamoto
    Hiroyuki Tsuchiya
    BMC Cancer, 16
12345